Silvia Boni

1.3k total citations
30 papers, 481 citations indexed

About

Silvia Boni is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Silvia Boni has authored 30 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Pharmacology. Recurrent topics in Silvia Boni's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Antibiotic Use and Resistance (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Silvia Boni is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Antibiotic Use and Resistance (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Silvia Boni collaborates with scholars based in Italy, United States and Argentina. Silvia Boni's co-authors include Emanuele Pontali, Matteo Bassetti, Claudio Viscoli, Stefania Artioli, Paolo Durando, Elda Righi, M.P. Molinari, F. Bobbio Pallavicini, Giovanni Orengo and Ernestina Repetto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Silvia Boni

27 papers receiving 468 citations

Peers

Countries citing papers authored by Silvia Boni

Since Specialization

Citations

This map shows the geographic impact of Silvia Boni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Boni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Boni more than expected).

Fields of papers citing papers by Silvia Boni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Boni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Boni. The network helps show where Silvia Boni may publish in the future.

Co-authorship network of co-authors of Silvia Boni

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Boni. A scholar is included among the top collaborators of Silvia Boni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Boni. Silvia Boni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multidose Dalbavancin Population Pharmacokinetic Analysis for Prolonged Target Attainment in Patients Requiring Long-Term Treatment 2025 ·Antibiotics ·(unknown), (unknown), Silvia Boni, Antonello Di Paolo, (unknown), Giuliana Cangemi, (unknown), Emanuele Pontali, Francesca Mattioli	1
2	Effects of Air Pollution on the Incidence of Respiratory Pathologies in the Cities of Ouagadougou and Bobo-Dioulasso, Burkina Faso 2025 ·Advances in Bioscience and Biotechnology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lassina Traoré, (unknown), (unknown), Silvia Boni, (unknown), Florencia Wendkuuni Djigma, Jacques Simporè	0
3	COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome 2024 ·Neurological Sciences ·Federico Massa, Tiziana Vigo, (unknown), Debora Giunti, (unknown), (unknown), (unknown), (unknown), Andrea Assini, Silvia Boni, D Rizzi, (unknown), (unknown), (unknown), Antonio Uccelli, Angelo Schenone, Diego Franciotta, Luana Benedetti	2
4	Ceftobiprole quantification in human serum by HPLC-UV to implement routine TDM in clinical practice 2024 ·Clinica Chimica Acta ·(unknown), Valéria Marini, (unknown), (unknown), (unknown), Fabio Piras, Filippo Del Puente, Silvia Boni, Emanuele Pontali, Francesca Mattioli	1
5	Innovative Approaches to Monitor Central Line Associated Bloodstream Infections (CLABSIs) Bundle Efficacy in Intensive Care Unit (ICU): Role of Device Standardized Infection Rate (dSIR) and Standardized Utilization Ratio (SUR)—An Italian Experience 2024 ·Journal of Clinical Medicine ·Silvia Boni, Marina Sartini, Filippo Del Puente, (unknown), (unknown), (unknown), Alessio Carbone, Marcello Feasi, (unknown), Marco Lattuada, (unknown), Martino Oliva, Andrea Parisini, Roberta Prinapori, (unknown), (unknown), Maria Luisa Cristina, Emanuele Pontali	1
6	Impact of the COVID-19 Pandemic on Epidemiology of Antibiotic Resistance in an Intensive Care Unit (ICU): The Experience of a North-West Italian Center 2023 ·Antibiotics ·Andrea Parisini, Silvia Boni, (unknown), (unknown), Filippo Del Puente, Marcello Feasi, Roberta Prinapori, Marco Lattuada, Marina Sartini, Maria Luisa Cristina, (unknown), Emanuele Pontali	8
7	An Overview on Candida auris in Healthcare Settings 2023 ·Journal of Fungi ·Maria Luisa Cristina, Anna Maria Spagnolo, Marina Sartini, Alessio Carbone, Martino Oliva, (unknown), Silvia Boni, Emanuele Pontali	43
8	Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in Pseudomonas aeruginosa in Argentina 2022 ·Interdisciplinary Perspectives on Infectious Diseases ·Silvia Boni, Gustavo H. Marín, (unknown), (unknown), (unknown), (unknown), (unknown), Alejandra Corso, (unknown), (unknown)	7
9	The use of continuous positive airway pressure during the second and third waves of the COVID-19 pandemic 2022 ·ERJ Open Research ·Claudia Brusasco, Francesco Corradi, Federico Dazzi, (unknown), Chiara Romei, Andrea Parisini, Silvia Boni, Gregorio Santori, Vito Brusasco, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
10	The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation 2021 ·Journal of NeuroVirology ·(unknown), Andrea Assini, Ilaria Gandoglia, Luana Benedetti, Silvia Boni, Emanuele Pontali, Marcello Feasi, Federica Gandolfo, Massimo Del Sette	8
11	Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales 2020 ·Antibiotics ·Antonio Vena, Daniele Roberto Giacobbe, Nadia Castaldo, Anna Maria Cattelan, Cristina Mussini, Roberto Luzzati, Francesco Giuseppe De Rosa, Filippo Del Puente, Claudio Maria Mastroianni, Antonio Cascio, Sergio Carbonara, Alessandro Capone, Silvia Boni, Chiara Sepulcri, Marianna Meschiari, (unknown), Alessandra Oliva, Silvia Corcione, Matteo Bassetti, (unknown)	76
12	‘Emergency exit’ of bone-marrow-resident CD34+DNAM-1brightCXCR4+-committed lymphoid precursors during chronic infection and inflammation 2015 ·Nature Communications ·Federica Bozzano, Francesco Marras, Maria Libera Ascierto, Claudia Cantoni, Giovanni Cenderello, Chiara Dentone, Antonio Di Biagio, Giancarlo Orofino, (unknown), Silvia Boni, Pasqualina De Leo, A. Picciotto, Fulvio Braido, Francesca Antonini, Ena Wang, Francesco M. Marincola, Lorenzo Moretta, Andrea De Maria	21
13	Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: Clinical considerations and disease burden 2009 ·Journal of Medical Virology ·Francesco Torre, Monica Basso, Edoardo G. Giannini, Marcello Feasi, Silvia Boni, Alessandro Grasso, Pasqualina De Leo, Ferdinando Dodi, Maria Grazia Marazzi, (unknown), (unknown), (unknown), (unknown), Paolo Borro, A. Picciotto	11
14	A Significant Proportion of Patients With Chronic Hepatitis B Who are Candidates for Antiviral Treatment are Untreated 2009 ·Journal of Clinical Gastroenterology ·Edoardo G. Giannini, Francesco Torre, Monica Basso, Marcello Feasi, Silvia Boni, Alessandro Grasso, Pasqualina De Leo, Ferdinando Dodi, Maria Grazia Marazzi, (unknown), (unknown), (unknown), (unknown), Paolo Borro, Vincenzo Savarino, A. Picciotto	21
15	Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections 2007 ·Journal of Antimicrobial Chemotherapy ·Matteo Bassetti, Ernestina Repetto, Elda Righi, Silvia Boni, (unknown), M.P. Molinari, Michele Mussap, Stefania Artioli, Filippo Ansaldi, Paolo Durando, Giovanni Orengo, F. Bobbio Pallavicini, Claudio Viscoli	135
16	Programmare il proprio life long learning: professionisti sanitari, ECM e aziende 2005 ·Silvia Boni	0
17	The relationship between ritonavir plasma trough concentration and virological and immunological response in HIV‐infected children 2002 ·HIV Medicine ·Giorgio Gatti, Emanuele Pontali, Silvia Boni, (unknown), Matteo Bassetti, Dante Bassetti	10
18	Compliance to combination antiretroviral therapy in HIV-1 infected children 2000 ·International Journal of Antimicrobial Agents ·Silvia Boni, Emanuele Pontali, (unknown), (unknown), Dante Bassetti	19
19	Does HGV–HIV co-infection exist? 2000 ·International Journal of Antimicrobial Agents ·Emanuele Pontali, (unknown), Matteo Bassetti, Silvia Boni, Dante Bassetti	3
20	Familial adult amyotrophic lateral sclerosis: report of cases 1992 ·Neurological Sciences ·M. Maurelli, Enrico Marchioni, Daniele Bosone, Silvia Boni, (unknown), (unknown), (unknown), F Savoldi	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact